These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 8558205

  • 61. Effects of the long-term depletion of reduced glutathione in mice administered L-buthionine-S,R-sulfoximine.
    Sun JD, Ragsdale SS, Benson JM, Henderson RF.
    Fundam Appl Toxicol; 1985 Oct; 5(5):913-9. PubMed ID: 2866140
    [Abstract] [Full Text] [Related]

  • 62. Combined effect of buthionine sulfoximine and cyclophosphamide upon murine tumours and bone marrow.
    Ono K, Komuro C, Tsutsui K, Shibamoto Y, Nishidai T, Takahashi M, Abe M, Shrieve DC.
    Br J Cancer; 1986 Nov; 54(5):749-54. PubMed ID: 3801271
    [Abstract] [Full Text] [Related]

  • 63. Selective toxicity of buthionine sulfoximine (BSO) to melanoma cells in vitro and in vivo.
    Révész L, Edgren MR, Wainson AA.
    Int J Radiat Oncol Biol Phys; 1994 May 15; 29(2):403-6. PubMed ID: 8195041
    [Abstract] [Full Text] [Related]

  • 64. Buthionine sulfoximine enhances glutathione-but attenuates glutamate-stimulated cell proliferation.
    Kang YJ.
    Cell Mol Biol Res; 1995 May 15; 41(2):131-6. PubMed ID: 8581064
    [Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 67.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 68. Combined effects of buthionine sulfoximine and cepharanthine on cytotoxic activity of doxorubicin to multidrug-resistant cells.
    Kisara S, Furusawa S, Murata R, Ogata M, Hikichi N, Takayanagi Y, Sasaki K.
    Oncol Res; 1995 May 15; 7(3-4):191-200. PubMed ID: 8555653
    [Abstract] [Full Text] [Related]

  • 69. Selective and synergistic activity of L-S,R-buthionine sulfoximine on malignant melanoma is accompanied by decreased expression of glutathione-S-transferase.
    Fruehauf JP, Zonis S, al-Bassam M, Kyshtoobayeva A, Dasgupta C, Milovanovic T, Parker RJ, Buzaid AC.
    Pigment Cell Res; 1997 Aug 15; 10(4):236-49. PubMed ID: 9263331
    [Abstract] [Full Text] [Related]

  • 70. SR-2508 plus buthionine sulfoximine or SR-2508 alone: effects on the radiation response and the glutathione content of a human tumor xenograft.
    Lespinasse F, Biscay P, Malaise EP, Guichard M.
    Radiat Res; 1987 Apr 15; 110(1):149-54. PubMed ID: 2951766
    [Abstract] [Full Text] [Related]

  • 71. Potentiation of melphalan cytotoxicity in human ovarian cancer cell lines by glutathione depletion.
    Green JA, Vistica DT, Young RC, Hamilton TC, Rogan AM, Ozols RF.
    Cancer Res; 1984 Nov 15; 44(11):5427-31. PubMed ID: 6488194
    [Abstract] [Full Text] [Related]

  • 72. Effect of DL-buthionine-S,R-sulfoximine on the growth of EMT6 and RIF mouse tumors.
    Miller AC, Henderson BW.
    J Natl Cancer Inst; 1986 Aug 15; 77(2):505-10. PubMed ID: 3461211
    [Abstract] [Full Text] [Related]

  • 73. [Increasing chemosensitivity to cisplatin by glutathione depletion with buthionine sulfoximine. In vitro and in vivo studies with a human squamous cell cancer line].
    Bier H.
    Laryngorhinootologie; 1990 Jan 15; 69(1):16-20. PubMed ID: 2310456
    [Abstract] [Full Text] [Related]

  • 74. Establishment of a melphalan-resistant rhabdomyosarcoma xenograft with cross-resistance to vincristine and enhanced sensitivity following buthionine sulfoximine-mediated glutathione depletion.
    Rosenberg MC, Colvin OM, Griffith OW, Bigner SH, Elion GB, Horton JK, Lilley E, Bigner DD, Friedman HS.
    Cancer Res; 1989 Dec 15; 49(24 Pt 1):6917-22. PubMed ID: 2582434
    [Abstract] [Full Text] [Related]

  • 75. Relationship of cellular glutathione to the cytotoxicity and resistance of seven platinum compounds.
    Meijer C, Mulder NH, Timmer-Bosscha H, Sluiter WJ, Meersma GJ, de Vries EG.
    Cancer Res; 1992 Dec 15; 52(24):6885-9. PubMed ID: 1458477
    [Abstract] [Full Text] [Related]

  • 76. Reduced thiol content in L1210 cells treated with BSO increases DNA crosslinking by melphalan.
    Dorr RT.
    Biochem Biophys Res Commun; 1987 Apr 14; 144(1):47-52. PubMed ID: 3579919
    [Abstract] [Full Text] [Related]

  • 77. Buthionine sulfoximine inhibition of cystine uptake and glutathione biosynthesis in human lung carcinoma cells.
    Brodie AE, Reed DJ.
    Toxicol Appl Pharmacol; 1985 Mar 15; 77(3):381-7. PubMed ID: 3975906
    [Abstract] [Full Text] [Related]

  • 78.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 79.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 80. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G, Marschke R, Camoriano JK, Sorensen JM, Sloan JA, Richardson RL.
    Cancer J Sci Am; 1997 Mar 15; 3(5):297-302. PubMed ID: 9327154
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.